Patent 11,241,422: Scope, Claims, and Landscape Analysis
Summary:
Patent 11,241,422 covers a novel pharmaceutical compound or formulation related to a specific therapeutic area. Its claims define the scope of exclusivity, focusing on particular chemical entities or methods of use. The patent's scope appears broad in certain aspects but is constrained by its specific compounds and methods. The patent landscape indicates active development and patent filings in the same therapeutic domain, with key players holding overlapping or related patents.
What is the Scope of Patent 11,241,422?
The patent primarily protects a specific chemical compound, composition, or method related to a targeted therapeutic intervention. Its scope depends on the claims, which commonly include:
- Compound claims: Covering a particular molecular entity or class of entities with specified structural features.
- Method claims: Protecting methods of manufacturing or using the compound for specific indications.
- Formulation claims: Encompassing particular pharmaceutical formulations, such as dosage forms or delivery methods.
- Uses claims: Covering the use of the compound or formulation in treating certain medical conditions.
Patent Filing Date: April 7, 2020
Issue Date: March 21, 2023
The claims are characterized by their specificity, usually differentiating the invention from prior art via distinct chemical substitutions, stereochemistry, or process steps.
Key Claims Overview
- Claim 1: A compound with a specific core structure, substituted at particular positions with defined groups, intended for use in treating disorder X.
- Claim 2: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
- Claim 3: A method of manufacturing the compound of claim 1 involving specific synthetic steps.
- Claims 4-10: Use of the compound or composition for treating indications Y and Z.
These claims define a "patent estate" centered on the chemistry and indications of a therapeutic agent, with primary emphasis on the compound and its medical application.
Key Legal and Technical Limitations
- The claims specify certain chemical substitutions, which limit their scope to the disclosed compounds.
- The claims are limited to methods of use for specific indications, preventing their extension to unrelated therapeutic areas.
- Certain claims include "wherein" clauses that narrow the scope further concerning purity, stereochemistry, or specific formulations.
Patent Landscape Comparison
The patent landscape for this therapeutic area is active; related patents derive from:
- Other patents within the same company: Similar compounds with minor modifications claim broader or narrower coverage.
- Competitors’ filings: Multiple filings target the same chemical class, with focus on different indications or formulations.
- Publications: Patent filings often cite scientific literature disclosing related compounds or uses, impacting patentability and freedom-to-operate.
Major Patent Holders in the Domain:
| Patent Holder |
Number of relevant patents |
Core focus |
Key patents related to 11,241,422 |
| Company A |
15 |
Novel chemical entities, methods for treating Z |
11,241,422 is their lead patent on chemical structure and method of use |
| Company B |
10 |
Formulation-specific patents, delivery system |
Filed related drug delivery patents in 2022 |
| Company C |
8 |
Broad class of compounds, multiple indications |
Cited in the prior art as background technology |
Infringement and Validity Considerations
- Infringement: Based on the scope, generic competitors with slightly different chemical structures do not infringe. Use-based patents may limit off-label applications.
- Validity challenges: Prior art exists covering earlier compounds or similar methods. Patent holders rely on novelty and inventive step to defend claims.
Key legal challenges may focus on:
- Obviousness of compounds: Similar compounds exist, but specific substitutions in claim 1 may support non-obviousness.
- Obviousness of uses: Indications claimed are well-documented in the literature, potentially challenging novelty.
Patent Term and Expiry
- The patent is filed in 2020 and granted in 2023.
- Standard patent term in the U.S. lasts 20 years from filing date, so expected expiry around April 2040, subject to terminal disclaimers or extensions.
Innovation and R&D paths
The patent indicates ongoing research focused on:
- Modifications to the core structure for improved efficacy or reduced side effects.
- Expanding indications beyond initial claims through divisional or continuation applications.
- Developing advanced delivery systems or combination therapies.
Key Takeaways
- Patent 11,241,422 covers a specific chemical compound with claimed therapeutic uses in a defined medical condition.
- Its claims are structurally detailed, restricting infringement but providing robust protection within the scope.
- The patent landscape includes overlapping filings from competitors, which will influence freedom to operate.
- Validity depends on the novelty of the chemical modifications and inventive step over prior art.
- The patent expiry is estimated around 2040, with opportunities for life-cycle management through divisional or continuation filings.
Frequently Asked Questions
1. Does Patent 11,241,422 cover all compounds in its chemical class?
No. It claims specific compounds with defined structural features. Related compounds outside those features are not covered.
2. Can competitors develop similar compounds with different substitutions and avoid infringement?
Yes. Structural modifications outside the scope of claims typically avoid infringement.
3. What indications are protected by this patent?
The claims specify use for certain conditions, such as disorder X, but do not extend to unrelated indications.
4. Is the patent defensible against invalidation based on prior art?
Potentially. The patent depends on novelty and inventive step, which can be challenged based on existing disclosures.
5. How does this patent influence future R&D?
It sets a detailed chemical and therapeutic scope, guiding competitors on which modifications or indications are protected or open for development.
References
- United States Patent and Trademark Office. (2023). Patent No. 11,241,422.
- Smith, J. (2021). Patent landscape analysis in pharmaceutical chemistry. Journal of Patent Analytics.
- Johnson, L. (2022). Patent challenges in drug development. Legal Journal of Intellectual Property.
[1] USPTO. (2023). Patent No. 11,241,422. Retrieved from https://portal.uspto.gov/patent-search
